Knight Therapeutics Inks License Agreement With Amneal Pharma For IPX203

Specialty pharmaceutical company Knight Therapeutics Inc. (GUD.TO) announced Thursday it has entered into an exclusive license agreement with Amneal Pharmaceuticals, Inc.

Related Keywords

Finland ,Finnish , ,Humana Inc ,Boeing ,Aviation Administration ,Nokia Corp ,Medicare Advantage ,Federal Aviation Administration ,Amneal Pharmaceuticals ,Knight Therapeutics ,Amrx ,Px203 ,Hud To ,